HALO logo
halo search icon
Akari Therapeutics Plc Sponsored ADR
Akari Therapeutics Plc Sponsored ADR
AKTX · NAS

Akari Therapeutics Plc Sponsored ADR

US$3.43

Price Arrow-0.31 (-8.289%)
20/05/2026 03:59:46 PM
All-Consensus
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Akari Therapeutics Plc Sponsored ADR Overview

AKTX Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About AKTX

icon

Telephone

1.929.274.7510

icon

Address

Suite 3300, 401 East Jackson Street, Tampa, FL 33602

Description

Akari Therapeutics Plc is a clinical-stage biopharmaceutical company. It engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. The company was founded on October 7, 2004 and is headquartered in Tampa, FL.

AKTX Price Chart

Key Stats

Market Cap

US$4.28M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 3.02 - 56.8

Trade Value (12mth)

US$50,926.00

1 week

7.16%

1 month

-36.29%

YTD

-67.76%

1 year

-92.46%

All time high

200000.00

Key Fundamentals

EPS 3 yr Growth

-100.00%

EBITDA Margin

0.00%

Operating Cashflow

-$11m

Free Cash Flow Return

-41.90%

ROIC

-68.60%

Interest Coverage

-12.70

Quick Ratio

0.40

Other Data

Shares Outstanding (Fully Diluted)

0m

HALO Sector

Healthcare

Next Company Report Date

03-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

AKTX Announcements

Latest Announcements

DateAnnouncements
20 May 26
20 May 26
15 April 26
31 March 26
27 March 26

AKTX Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
$locklocklocklockN/AN/AN/Alocklocklock
EPS (Fully Diluted)
$locklocklocklock-82.11-66.31-0.52locklocklock
Growth
%locklocklocklock100N/AN/Alocklocklock
PE
XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
XlocklocklocklockN/AN/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Akari Therapeutics Plc Sponsored ADR (AKTX:NAS)?
Halo FAQ
The current share price of Akari Therapeutics Plc Sponsored ADR (AKTX:NAS) is USD$3.43.
What is the 52-week high share price for Akari Therapeutics Plc Sponsored ADR (AKTX:NAS)?
Halo FAQ
The 52-week high share price for Akari Therapeutics Plc Sponsored ADR (AKTX:NAS) is USD$56.80.
What is the 52-week low share price for Akari Therapeutics Plc Sponsored ADR (AKTX:NAS)?
Halo FAQ
The 52-week low share price for Akari Therapeutics Plc Sponsored ADR (AKTX:NAS) is USD$3.02.
What is the dividend yield for Akari Therapeutics Plc Sponsored ADR (AKTX:NAS)?
Halo FAQ
Akari Therapeutics Plc Sponsored ADR (AKTX:NAS) does not pay a dividend.
What was Akari Therapeutics Plc Sponsored ADR (AKTX:NAS) last dividend payment?
Halo FAQ
Akari Therapeutics Plc Sponsored ADR (AKTX:NAS) does not pay a dividend.
What is the franking level for Akari Therapeutics Plc Sponsored ADR (AKTX:NAS)?
Halo FAQ
Akari Therapeutics Plc Sponsored ADR (AKTX:NAS) has a franking level of 0.00%.
In which sector is Akari Therapeutics Plc Sponsored ADR (AKTX:NAS) classified?
Halo FAQ
Akari Therapeutics Plc Sponsored ADR (AKTX:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.